Hurler syndrome pathophysiology: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
[[Category:Lysosomal storage diseases]] | [[Category:Lysosomal storage diseases]] | ||
Revision as of 02:19, 26 February 2013
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Hurler Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hurler syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Hurler syndrome pathophysiology |
|
Risk calculators and risk factors for Hurler syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Children born to an MPS I parent carry a defective IDUA gene, which has been mapped to the 4p16.3 site on chromosome 4. The gene is named IDUA because of its iduronidase enzyme protein product. As of 2001, 52 different mutations in the IDUA gene have been shown to cause Hurler syndrome.
Because Hurler syndrome is an autosomal recessive disorder, affected persons have two bad copies of the IDUA gene. If someone is born with one normal and one defective copy of the gene he is called a carrier and will produce less alpha-L-iduronidase than an individual with two normal copies of the gene. The reduced production of the enzyme, however, is sufficient for normal function and the person should not show any symptoms of the disease.